Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics Inc (VVOS)
3.54 x 1 3.75 x 1
Post-market by (Cboe BZX)
3.54 -0.46 (-11.50%) 02/18/25 [NASDAQ]
3.54 x 1 3.75 x 1
Post-market 3.54 unch (unch) 19:59 ET
Quote Overview for Tue, Feb 18th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
3.40
Day High
4.27
Open 3.98
Previous Close 4.00 4.00
Volume 506,500 506,500
Avg Vol 188,475 188,475
Stochastic %K 29.22% 29.22%
Weighted Alpha -1.58 -1.58
5-Day Change -0.59 (-14.29%) -0.59 (-14.29%)
52-Week Range 1.91 - 6.28 1.91 - 6.28
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,558
  • Shares Outstanding, K 5,890
  • Annual Sales, $ 13,800 K
  • Annual Income, $ -13,580 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 7.47
  • Price/Sales 0.87
  • Price/Cash Flow N/A
  • Price/Book 2.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.43
  • Number of Estimates 1
  • High Estimate -0.43
  • Low Estimate -0.43
  • Prior Year -3.05
  • Growth Rate Est. (year over year) +85.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.40 +4.08%
on 02/18/25
Period Open: 5.74
5.83 -39.28%
on 01/21/25
-2.20 (-38.33%)
since 01/17/25
3-Month
2.51 +41.04%
on 11/19/24
Period Open: 2.71
6.28 -43.63%
on 01/17/25
+0.83 (+30.63%)
since 11/18/24
52-Week
1.91 +85.34%
on 05/30/24
Period Open: 5.25
6.28 -43.63%
on 01/17/25
-1.71 (-32.57%)
since 02/16/24

Most Recent Stories

More News
Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.

VVOS : 3.54 (-11.50%)
Best Momentum Stocks to Buy for January 8th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 8:Vivos Therapeutics, Inc. VVOS: This medical technology company has a Zacks Rank #1 and...

YELP : 38.11 (+2.06%)
VVOS : 3.54 (-11.50%)
DXC : 21.32 (+4.66%)
Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

VVOS : 3.54 (-11.50%)
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update

VVOS : 3.54 (-11.50%)
Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

VVOS : 3.54 (-11.50%)
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

VVOS : 3.54 (-11.50%)
Vivos Therapeutics (NASDAQ: VVOS) Secures Strategic Alliances to Enhance Clear Aligner Offerings and Bolster Revenue Streams

Vivos Therapeutics Announces Strategic Agreements with Ormco and On Demand Orthodontist Vivos Therapeutics, Inc. (NASDAQ: VVOS), a prominent medical device

VVOS : 3.54 (-11.50%)
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances

Vivos Therapeutics, Inc . (NASDAQ: VVOS) is pleased to announce that it has received multiple Class I clearances by the Therapeutic Goods Administration for multiple indications to include the treatment...

VVOS : 3.54 (-11.50%)
Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea

Study Recently Presented at the SLEEP 2022 Annual Meeting...

VVOS : 3.54 (-11.50%)
Vivos Therapeutics Schedules First Quarter 2022 Financial Results Conference Call

Call Scheduled for Monday, May 16, 2022 at 5:00 pm ET...

VVOS : 3.54 (-11.50%)

Business Summary

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

See More

Key Turning Points

3rd Resistance Point 4.94
2nd Resistance Point 4.61
1st Resistance Point 4.07
Last Price 3.54
1st Support Level 3.20
2nd Support Level 2.87
3rd Support Level 2.34

See More

52-Week High 6.28
Fibonacci 61.8% 4.61
Fibonacci 50% 4.10
Fibonacci 38.2% 3.58
Last Price 3.54
52-Week Low 1.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion